Pharmeasy Reports Harish

Report for Vuyyooru Harish Kumar Reddy(23Y/M)
Tests asked Meslg, Mumpg + 1 Others
Test date 06 Nov 2022 Report status Complete Report

Name : VUYYOORU HARISH KUMAR ADDRESS :
REDDY(23Y/M)
Ref. By : SELF
7-4-387/2 NAVAJEEVAN NAGAR NEAR GANESH
TEMPLE BALANAGAR FEROZGUDA BOWIN PALLE
HYD HYDERABAD
Report Availability Summary
Full Report Available
Note : This is summary page. Please refer to the table below for the details
Test Report Status
● MEASLES ANTIBODY - IGG Available
● MUMPS ANTIBODY - IGG Available
● RUBELLA - IgG Available
Note : Underlined values are Critical Values, Clinician's attention required. Clinically Tested by : Thyrocare Technologies Ltd.
NAME : VUYYOORU HARISH KUMAR REDDY(23Y/M) HOME COLLECTION :
REF. BY : SELF 7-4-387/2 NAVAJEEVAN NAGAR NEAR GANESH
TEST ASKED : MEASLES ANTIBODY - IGG,MUMPS ANTIBODY - HYD HYDERABAD
IGG,RUBELLA - IgG
TEST NAME TECHNOLOGY VALUE UNITS

MEASLES ANTIBODY - IGG C.L.I.A <5 AU/mL
Reference Range :-
Negative : < 13.5

Equivocal : 13.5 - 16.5
Positive : > 16.5
Clinical Significance:
Measles is acute, highly contagious disease. Measles symptoms appear in two stages. In first stage, the individual may have runny
nose, cough and a slight fever. The second stage consist of high fever, red blotchy rash.
Specifications:
Intra assay Precision: 8% (%CV), Inter Assay Precision: 15.8% (%CV), Sensitivity: 94.70%, Specificity: 97.40%
Kit Validation References:

TH.TULCHINSKY et.al measles control in developing and developed countries : the case for a two-dose policy. Bull World health organ
,71(1): 93-103(1993)
Please correlate with clinical conditions.

Method:- SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY
Sample Collected on (SCT) : 06 Nov 2022 12:07

Sample Received on (SRT) : 07 Nov 2022 04:18
Report Released on (RRT) : 07 Nov 2022 10:49
Sample Type : SERUM
Labcode : 0611003161/PE045 Dr Kuldeep Singh MD(Path) Dr Sachin Patil MD(Path)

Barcode : X6250589 Page : 1 of 3
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd
REF. BY : SELF 7-4-387/2 NAVAJEEVAN NAGAR NEAR GANESH
TEST ASKED : MEASLES ANTIBODY - IGG,MUMPS ANTIBODY - HYD HYDERABAD
IGG,RUBELLA - IgG

MUMPS ANTIBODY - IGG C.L.I.A 271 AU/mL
Reference Range :-
Negative : < 9
Equivocal : 9 - 11
Positive : > 11
Clinical Significance:
Mumps is a viral infection caused by paramyxovirus that primarily affects saliva-producing (salivary) glands that are located near ears.
Mumps can cause swelling in one or both of those glands. Signs and symptoms of mumps may include:
1. Pain in the swollen salivary glands on one or both sides of your face
2. Pain while chewing or swallowing
It spreads easily from person to person through infected saliva. If individual is not immune, they can contract mumps by breathing in
saliva droplets from an infected person who has just sneezed or coughed. Assay aids in detection of IGG antibodies against MUMPS
Virus in Patient serum. Presence of these IGG antibody indicates that the person had previous infection or was vaccinated against
MUMPS.
Specifications:
Intra- assay : 8.34 % , Inter assay - 9.4 % ; Specificity - 98.2 %, Sensitivity - 98.5 %
Kit validation reference:

C.E. CAPLAN Mumps in the era of vaccines. C.M.A.J., 160 (6) : 865-866 (1999).

Method:- SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY

Sample Type : SERUM
Labcode : 0611003161/PE045 Dr Kuldeep Singh MD(Path) Dr Sachin Patil MD(Path)

Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd
7-4-387/2 NAVAJEEVAN NAGAR NEAR GANESH TEMPLE
REF. BY : SELF BALANAGAR FEROZGUDA BOWIN PALLE HYD HYDERABAD
TEST ASKED : MEASLES ANTIBODY - IGG,MUMPS ANTIBODY -
IGG,RUBELLA - IgG
RUBELLA - IgG E.L.I.S.A 4.81 OD Ratio
Reference Range :-
Negative : < 0.70
Equivocal : 0.70 - 1.30
Positive : > 1.30
Method :
RB_G - Solid Phase Enzyme Immunoassay
~~ End of report ~~

Sample Type : SERUM
Labcode : 0611003161/PE045 Dr Sachin Patil MD(Path)
Dr Kuldeep Singh MD(Path)
Note:- Underlined values are Critical Values, Clinician's attention required. Clinically Tested by :Thyrocare Technologies Ltd - (CAP & NABL accredited)

Pharmeasy Reports Harish

Uploaded by

Copyright:

Available Formats

Pharmeasy Reports Harish

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Pharmeasy Reports Harish

Uploaded by

Copyright:

Available Formats

Report for Vuyyooru Harish Kumar Reddy(23Y/M)

Tests asked Meslg, Mumpg + 1 Others

Test date 06 Nov 2022 Report status Complete Report

Report Availability Summary

Full Report Available

Test Report Status

● MEASLES ANTIBODY - IGG Available

● MUMPS ANTIBODY - IGG Available

● RUBELLA - IgG Available

TEST NAME TECHNOLOGY VALUE UNITS

Negative : < 13.5

Kit Validation References:

Please correlate with clinical conditions.

Sample Collected on (SCT) : 06 Nov 2022 12:07

Sample Type : SERUM

Labcode : 0611003161/PE045 Dr Kuldeep Singh MD(Path) Dr Sachin Patil MD(Path)

TEST NAME TECHNOLOGY VALUE UNITS

Kit validation reference:

Please correlate with clinical conditions.

Sample Collected on (SCT) : 06 Nov 2022 12:07

Sample Type : SERUM

Labcode : 0611003161/PE045 Dr Kuldeep Singh MD(Path) Dr Sachin Patil MD(Path)

TEST NAME TECHNOLOGY VALUE UNITS

RUBELLA - IgG E.L.I.S.A 4.81 OD Ratio

Please correlate with clinical conditions.

Sample Collected on (SCT) : 06 Nov 2022 12:07

You might also like